ZCM
LLY icon

Zebra Capital Management’s Eli Lilly LLY Stock Holding History

Zebra Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,542
Closed -$282K – 347
2019
Q2 		$282K Buy
2,542
+817
+47% +$96.2K 0.15% 325
2019
Q1 		$224K Buy
+1,725
New +$210K 0.12% 363

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zebra Capital Management's LLY Position: Q3 2019 in Review

Zebra Capital Management sold out of Eli Lilly (LLY) in Q3 2019, closing a stake of 2,542 shares — an estimated $282K sold.

Zebra Capital Management first reported a position in LLY in Q1 2019 and held it in 2 quarters. The position peaked at $282K in Q2 2019. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Zebra Capital Management reported no remaining Eli Lilly position as of Q3 2019 after selling out during the quarter.
  • Zebra Capital Management sold 2,542 Eli Lilly shares in Q3 2019, an estimated $282K.
  • Zebra Capital Management first reported a position in Eli Lilly in Q1 2019 and held it in 2 quarters.
  • Zebra Capital Management's Eli Lilly position peaked at $282K in Q2 2019.
  • 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Zebra Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.